Clik here to view.
Parse Biosciences与Hamilton、Opentrons Labworks和SPT Labtech合作推出实验室自动化供应商计划
西雅图 (美国商业资讯)– 领先的易用型可扩展单细胞测序解决方案提供商Parse Biosciences今天宣布，该公司已推出实验室自动化提供商计划，使自动化提供商能够随时支持Parse的Evercode™单细胞产品的应用。通过将功能强大的自动化技术与Parse Evercode平台相结合，客户将获得前所未有的高通量单细胞测序能力，使他们能够迅速为大规模研究生成洞察。...
View ArticleClik here to view.
パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携
SEATTLE （ビジネスワイヤ） — アクセスが容易で拡張性に優れたシングルセル・シーケンシング・ソリューションの大手プロバイダーであるパース・バイオサイエンシズ（パース）は、研究室用自動化プロバイダー・プログラムのローンチを発表しました。このプログラムにより、自動化プロバイダーは当社のEvercode™シングルセル製品の導入を簡単にサポートできるようになります。強力な自動化とParse...
View ArticleClik here to view.
Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
SAN DIEGO Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor...
View ArticleClik here to view.
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
CAMBRIDGE, Mass. ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology...
View ArticleClik here to view.
ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
马萨诸塞州剑桥 (美国商业资讯)– ReNAgade Therapeutics是一家致力于开发RNA药物无限潜力的公司。该公司今天宣布，将继续致力于通过支持GanNA Bio的持续研究以及将GanNA Bio的关键单品整合到ReNAgade生态系统中，探索糖生物学的治疗潜力。GanNA创始人Carolyn Bertozzi博士和Richard D....
View ArticleClik here to view.
ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — RNA医薬品の無限の可能性にチャレンジする企業であるReNAgadeセラピューティクスは、GanNA...
View ArticleClik here to view.
CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA...
CAMBRIDGE, Mass. Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT...
View ArticleClik here to view.
ATLATL Scientific and Miltenyi Biotec: A Five-Year Partnership Driving...
SINGAPORE ATLATL Scientific and Miltenyi Biotec are celebrating a landmark five-year partnership, marking a journey of collaboration and innovation in the biotech sector. With a strong foundation...
View ArticleClik here to view.
Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
TOKYO & NEW YORK & DÜSSELDORF, Germany Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment. The next generation of oligo...
View ArticleClik here to view.
Parse Biosciences推出单细胞免疫分析产品
西雅图 (美国商业资讯)– Parse Biosciences是一家领先的提供易于获取和可扩展的单细胞测序解决方案的供应商。该公司今天宣布推出Evercode™ BCR，并扩展了其现有的Evercode™ TCR产品线。新的BCR解决方案和现有TCR产品线的更新扩展了Parse的单细胞产品组合，将使研究人员能够以前所未有的分辨率和规模研究免疫复合物。 Evercode...
View ArticleClik here to view.
Clik here to view.
Biocytogen Enters Into Evaluation and Potential Licensing Agreement With...
BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a...
View ArticleClik here to view.
Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk...
HONG KONG Inocras Hong Kong, in partnership with Cancerinformation.com.hk Charity Foundation (CICF) and generously sponsored by AstraZeneca Hong Kong, is pleased to announce the launch of ‘HRDetect’...
View ArticleClik here to view.
Modalis Therapeutics Reports Data Supporting Development of a Transformative...
TOKYO & WALTHAM, Mass. Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative drugs for the treatment of rare genetic diseases, utilizing its...
View ArticleClik here to view.
Clik here to view.
ANESSA Launching “ANESSA Sunshine Project” in 12 Asian countries/regions to...
TOKYO ANESSA, the No. 1 suncare brand in Asia*1 from Shiseido, is proud to unveil the ANESSA Sunshine Project, a groundbreaking initiative to promote children’s holistic well-being by safely...
View ArticleClik here to view.
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation...
GUILFORD, Conn. & SHANGHAI Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral,...
View ArticleClik here to view.
Inocras and IMBdx Announce Strategic Partnership to Transform Cancer Patient...
SAN DIEGO Inocras and IMBdx have announced a partnership aimed at enhancing care for cancer patients in the U.S. Through this partnership, Inocras, a leader in whole genome sequencing diagnostics,...
View ArticleClik here to view.
iCell Gene Therapeutics Announces Positive Clinical Data from Investigator...
STONY BROOK, N.Y. iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for autoimmune disorders and cancer, today announced the publication in Annals of the...
View ArticleClik here to view.
Morinaga Milk’s New Research Breakthrough Backed the Superiority of its...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, has announced a groundbreaking discovery in the fundamental research of Human-Residential...
View Article